![Second-generation Insulin Analogues – a Review of Recent Real-world Data and Forthcoming Head-to-head Comparisons | [current-page:pager]touchENDOCRINOLOGY Second-generation Insulin Analogues – a Review of Recent Real-world Data and Forthcoming Head-to-head Comparisons | [current-page:pager]touchENDOCRINOLOGY](https://www.touchendocrinology.com/wp-content/uploads/sites/5/2018/05/Figure6-Patient-randomisation.png)
Second-generation Insulin Analogues – a Review of Recent Real-world Data and Forthcoming Head-to-head Comparisons | [current-page:pager]touchENDOCRINOLOGY
![New Generation Basal Insulin and Insulin-GLP1 Combinations:Practical Considerations| CME Dr. NG - YouTube New Generation Basal Insulin and Insulin-GLP1 Combinations:Practical Considerations| CME Dr. NG - YouTube](https://i.ytimg.com/vi/K87hPJOFvk0/sddefault.jpg)
New Generation Basal Insulin and Insulin-GLP1 Combinations:Practical Considerations| CME Dr. NG - YouTube
![Classification of new-generation insulin sensitizers based on their... | Download Scientific Diagram Classification of new-generation insulin sensitizers based on their... | Download Scientific Diagram](https://www.researchgate.net/profile/Wei-Chen-42/publication/317343497/figure/fig1/AS:1086530093359223@1636060369734/Classification-of-new-generation-insulin-sensitizers-based-on-their-mechanisms-or_Q640.jpg)
Classification of new-generation insulin sensitizers based on their... | Download Scientific Diagram
![Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 2 diabetes (BEGIN Basal-Bolus Type 2): a phase 3, randomised, open-label, treat-to-target non-inferiority trial - Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 2 diabetes (BEGIN Basal-Bolus Type 2): a phase 3, randomised, open-label, treat-to-target non-inferiority trial -](https://www.thelancet.com/cms/attachment/82b45a1c-865f-4706-9292-abd3dfdaf8af/gr1_lrg.gif)
Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 2 diabetes (BEGIN Basal-Bolus Type 2): a phase 3, randomised, open-label, treat-to-target non-inferiority trial -
![No insulin degludec dose adjustment required after aerobic exercise for people with type 1 diabetes: the ADREM study | SpringerLink No insulin degludec dose adjustment required after aerobic exercise for people with type 1 diabetes: the ADREM study | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00125-023-05893-9/MediaObjects/125_2023_5893_Figb_HTML.png)
No insulin degludec dose adjustment required after aerobic exercise for people with type 1 diabetes: the ADREM study | SpringerLink
![PDF] A New-Generation Ultra-Long-Acting Basal Insulin With a Bolus Boost Compared With Insulin Glargine in Insulin-Naïve People With Type 2 Diabetes | Semantic Scholar PDF] A New-Generation Ultra-Long-Acting Basal Insulin With a Bolus Boost Compared With Insulin Glargine in Insulin-Naïve People With Type 2 Diabetes | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/70f0bb214ea2ff0f2d98155885e4bc57202ac108/3-Figure1-1.png)
PDF] A New-Generation Ultra-Long-Acting Basal Insulin With a Bolus Boost Compared With Insulin Glargine in Insulin-Naïve People With Type 2 Diabetes | Semantic Scholar
![Second-generation Insulin Analogues – a Review of Recent Real-world Data and Forthcoming Head-to-head Comparisons | [current-page:pager]touchENDOCRINOLOGY Second-generation Insulin Analogues – a Review of Recent Real-world Data and Forthcoming Head-to-head Comparisons | [current-page:pager]touchENDOCRINOLOGY](https://www.touchendocrinology.com/wp-content/uploads/sites/5/2018/05/Figure5-BRIGHT-study-design.png)
Second-generation Insulin Analogues – a Review of Recent Real-world Data and Forthcoming Head-to-head Comparisons | [current-page:pager]touchENDOCRINOLOGY
![Bionic pancreas improves type 1 diabetes management compared to standard insulin delivery methods | National Institutes of Health (NIH) Bionic pancreas improves type 1 diabetes management compared to standard insulin delivery methods | National Institutes of Health (NIH)](https://www.nih.gov/sites/default/files/news-events/news-releases/2022/20220928-pancreas.png)
Bionic pancreas improves type 1 diabetes management compared to standard insulin delivery methods | National Institutes of Health (NIH)
![Medicina | Free Full-Text | Recent Advances in the Treatment of Insulin Resistance Targeting Molecular and Metabolic Pathways: Fighting a Losing Battle? Medicina | Free Full-Text | Recent Advances in the Treatment of Insulin Resistance Targeting Molecular and Metabolic Pathways: Fighting a Losing Battle?](https://www.mdpi.com/medicina/medicina-58-00472/article_deploy/html/images/medicina-58-00472-g001.png)
Medicina | Free Full-Text | Recent Advances in the Treatment of Insulin Resistance Targeting Molecular and Metabolic Pathways: Fighting a Losing Battle?
![Second-generation Insulin Analogues – a Review of Recent Real-world Data and Forthcoming Head-to-head Comparisons | [current-page:pager]touchENDOCRINOLOGY Second-generation Insulin Analogues – a Review of Recent Real-world Data and Forthcoming Head-to-head Comparisons | [current-page:pager]touchENDOCRINOLOGY](https://www.touchendocrinology.com/wp-content/uploads/sites/5/2018/05/Figure1-Incidence-of-hypoglycaemia.png)
Second-generation Insulin Analogues – a Review of Recent Real-world Data and Forthcoming Head-to-head Comparisons | [current-page:pager]touchENDOCRINOLOGY
![Insulin- Pharmacology, Therapeutic Regimens and Principles of Intensive Insulin Therapy - Endotext - NCBI Bookshelf Insulin- Pharmacology, Therapeutic Regimens and Principles of Intensive Insulin Therapy - Endotext - NCBI Bookshelf](https://www.ncbi.nlm.nih.gov/books/NBK278938/bin/insulin-pharmacology-Image002.jpg)
Insulin- Pharmacology, Therapeutic Regimens and Principles of Intensive Insulin Therapy - Endotext - NCBI Bookshelf
![Review of the Next Generation of Long-Acting Basal Insulins: Insulin Degludec and Insulin Glargine. | Semantic Scholar Review of the Next Generation of Long-Acting Basal Insulins: Insulin Degludec and Insulin Glargine. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/4dee2aba3dcad1dc81aa630dab2c0647695dd043/3-Table1-1.png)